201.8K
Downloads
284
Episodes
Hosted by Ryan Irvine & Aaron Dunn, the podcast is highly interactive taking listener questions each week on individual Canadian & U.S. stocks as well as stock portfolio building strategies. The podcast focuses on high quality Canadian Dividend growth stocks, unknown & profitable Canadian Small-Cap stocks, U.S. tech leaders and high growth small-cap stocks. We also provide simple portfolio building tips for DIY investors. Weekly show highlights include: - Case For & Against Any Stock: our Ryan, Aaron & Brennan debate the pro's & con's of investing in a stock from a fundamental perspective and one of our analysts acts as judge, jury, and executioner to settle the lively debate. -Your Stock, Our Take Segment: Need a sober second opinion on any stock in your portfolio? Send a question to our Your Stock Our Take segment and we will review the business based on our BUY/SELL/HOLD criteria. - DIY Portfolio Building Tips: Interested in building your own DIY stock portfolio while paying less fees? Listen-in every week to uncover tips on how to take control of your financial future and dissect the hot button topics and stocks of the week. - Dividend Growth Stocks & Profitable Unknown Small-Caps: KeyStone’s Stock Talk Podcast is the only podcast talking Canadian & U.S. stocks across all market sectors. From profitable, unknown small-caps to great dividend paying mid and large caps, it is they type of stock discussion you can find nowhere else. - Canadian Stock Content: For Canadian investors & created by Canadian investors, we actually talk Canadian stocks. Real stocks to add to your watch list and, perhaps most importantly, which stocks to potentially avoid. - Hot Topics: From the FAANGs, AI, SaaS, cloud computing, and cybersecurity to gold, Cannabis, renewable & alternative energy to day trading vs. long-term investing, we have you covered.
Episodes
Wednesday Feb 20, 2019
Wednesday Feb 20, 2019
This week in our Your Stock, Our Take segment we look at BioSyent Inc. (RX:TSX-V), a Canadian specialty pharmaceutical company. Primary product is FeraMAX®, an over-the-counter iron supplement. A listener asks if it is time to take a look at this stock again in 2019? Our Star of the week is (should be no stranger to KeyStone Clients) - Zynex Inc. (ZYXI: NASDAQ), which manufactures and sells non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics. Primary offering electrotherapy medical devices used for pain management and rehabilitation. The stock has surged 82% year-to-date and roughly the same amount since our BUY recommendation just over a year ago. The company recently announced that it has graduated to the NASDAQ exchange and will be announcing its 2018 annual results and outlook next week. Finally, our Dog of the week is Lassonde Industries Inc. (LAS.A:TSX), a North American leader in the development, manufacture and sale of a wide range of ready-to-drink fruit and vegetable juices and drinks. The stock is down over 13% in the last couple days. Is it a Dog or an opportunity?
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.